Michael O'Dwyer to Treatment Outcome
This is a "connection" page, showing publications Michael O'Dwyer has written about Treatment Outcome.
Connection Strength
0.483
-
CyBorD-DARA in Newly Diagnosed Transplant-Eligible Multiple Myeloma: Results from the 16-BCNI-001/CTRIAL-IE 16-02 Study Show High Rates of MRD Negativity at End of Treatment. Clin Lymphoma Myeloma Leuk. 2022 11; 22(11):847-852.
Score: 0.124
-
CyBorD-DARA is potent initial induction for MM and enhances ADCP: initial results of the 16-BCNI-001/CTRIAL-IE 16-02 study. Blood Adv. 2019 06 25; 3(12):1815-1825.
Score: 0.100
-
Epigenetic regulatory pathways involving microRNAs may modulate the host immune response following major trauma. J Trauma Acute Care Surg. 2015 Nov; 79(5):766-72.
Score: 0.078
-
Outcome in elderly acute myeloid leukaemia. Ir Med J. 2008 Nov-Dec; 101(10):307-10.
Score: 0.048
-
Daratumumab/lenalidomide/dexamethasone in transplant-ineligible newly diagnosed myeloma: MAIA long-term outcomes. Leukemia. 2025 Apr; 39(4):942-950.
Score: 0.037
-
Consensus guidelines and recommendations for the management and response assessment of chimeric antigen receptor T-cell therapy in clinical practice for relapsed and refractory multiple myeloma: a report from the International Myeloma Working Group Immunotherapy Committee. Lancet Oncol. 2024 Aug; 25(8):e374-e387.
Score: 0.035
-
Risk adjusted therapy in chronic lymphocytic leukemia: a phase II cancer trials Ireland (CTRIAL-IE [ICORG 07-01]) study of fludarabine, cyclophosphamide, and rituximab therapy evaluating response adapted, abbreviated frontline therapy with FCR in non-del(17p) CLL. Leuk Lymphoma. 2018 06; 59(6):1338-1347.
Score: 0.022
-
Effect of a 6-Week Active Play Intervention on Fundamental Movement Skill Competence of Preschool Children. Percept Mot Skills. 2017 Apr; 124(2):393-412.
Score: 0.021
-
A multi-centre retrospective study of rituximab use in the treatment of relapsed or resistant warm autoimmune haemolytic anaemia. Br J Haematol. 2013 Oct; 163(1):118-22.
Score: 0.017